Business Services
Retail
Biopharmaceutical

Caladrius Biosciences

$2.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (2.08%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CLBS and other stocks, options, ETFs, and crypto commission-free!

About CLBS

Caladrius Biosciences, Inc. Common Stock, also called Caladrius Biosciences, is a biopharmaceutical company, which engages in developing products in cardiovascular and autoimmune disease that have the potential to restore the health of people with chronic illnesses. Read More Its product pipeline includes CLBS12, CLBS14, and CLBS03. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.

Employees
25
Headquarters
Basking Ridge, New Jersey
Founded
1980
Market Cap
30.00M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
49.82K
High Today
$3.10
Low Today
$2.90
Open Price
$2.90
Volume
52.90K
52 Week High
$6.83
52 Week Low
$2.16

Collections

Business Services
Retail
Biopharmaceutical
Pharmaceutical
Health
2015 IPO
US
North America

CLBS Earnings

-$0.78
-$0.64
-$0.50
-$0.36
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.